Drug Type Small molecule drug |
Synonyms AQX-C5 |
Target |
Action activators |
Mechanism SHIP1 activators(Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1 activators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Lymphocytic Leukemia | Preclinical | Czechia | 01 Oct 2020 |